From Diamond Princess to Cordelia Cruises (Empress): Déjà vu in the New Year, lessons unlearned! Chakrabarty, Nivedita; Mahajan, Abhishek Chakrabarty, Nivedita; Mahajan, Abhishek Less Cancer Research, Statistics, and Treatment. 5(1):1-4, Jan-Mar 2022. Favorite PDF Permissions Open
Optimizing the bed distribution system in resource-constrained settings Mishra, Bal Krishna; Kapoor, Akhil Mishra, Bal Krishna; Kapoor, Akhil Less Cancer Research, Statistics, and Treatment. 5(1):5-6, Jan-Mar 2022. Favorite PDF Permissions Open
Impact of COVID-19 on global waste and the need for mitigation Chakrabarty, Nivedita; Shukla, Shreya; Mahajan, Abhishek Chakrabarty, Nivedita; Shukla, Shreya; Mahajan, Abhishek Less Cancer Research, Statistics, and Treatment. 5(1):7-10, Jan-Mar 2022. Favorite PDF Permissions Open
Outcome of COVID-19 in Indian patients with cancer: A multicenter, retrospective study Seshachalam*, Arun; Saju*, S. V.; Raju, Honey Susan; More Seshachalam*, Arun; Saju*, S. V.; Raju, Honey Susan; Rathnam, Krishnakumar; Janarthinakani, Murugesan; Prasad, Krishna; Patil, Channappa; Anoop, Parameswaran; Reddy, Neelesh; Anumula, Satish Kumar; Golamari, Krishna Reddy; Bodepudi, Sravan Kumar; Danthala, Madhav; Malipatil, Basawantrao; Senthilkumar, G; Niraimathi, Kesavan; Raman, S. G. Less Cancer Research, Statistics, and Treatment. 5(1):11-18, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Deep learning-based COVID-19 triage tool: An observational study on an X-ray dataset Mahajan, Abhishek; Pawar, Vivek; Punia, Vivek; More Mahajan, Abhishek; Pawar, Vivek; Punia, Vivek; Vaswani, Aakash; Gupta, Piyush; S. Bharadwaj, K. S.; Salunke, Arvind; Palande, Sujit D.; Banderkar, Kalashree; Apparao, M. L. V. Less Cancer Research, Statistics, and Treatment. 5(1):19-25, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Preference and Satisfaction with Cancer Institute Quality of Life Questionnaire, (QLQ) V. II and EORTC QLQ-C30 Tamil version: An observational study Athikesavan, Sasikala; Elangovan, Vidhubala; Chidambaram, Sundaramoorthy; More Athikesavan, Sasikala; Elangovan, Vidhubala; Chidambaram, Sundaramoorthy; Veeraiah, Surendran Less Cancer Research, Statistics, and Treatment. 5(1):26-34, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Construction and validation of palliative care nursing theory guidelines for patients with advanced cancer Kalyani, C. Vasantha; Rohilla, Kusum K.; Gupta, Amit; More Kalyani, C. Vasantha; Rohilla, Kusum K.; Gupta, Amit; Gupta, Sweety; Gupta, Manoj; Matella, Nirmal Less Cancer Research, Statistics, and Treatment. 5(1):35-44, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Impact of demographic factors on delayed presentation of oral cancers: A questionnaire-based cross-sectional study from a rural cancer center Singla, Anshul; Goel, Alok K.; Oberoi, Simmi; More Singla, Anshul; Goel, Alok K.; Oberoi, Simmi; Jain, Shivani; Singh, Deepak; Kapoor, Rakesh Less Cancer Research, Statistics, and Treatment. 5(1):45-51, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Diagnostic accuracy of mammography in characterizing breast masses using the 5th edition of BI-RADS: A retrospective study Mohapatra, Suvendu Kumar; Das, Prafulla Kumar; Nayak, Rashmita Binod; More Mohapatra, Suvendu Kumar; Das, Prafulla Kumar; Nayak, Rashmita Binod; Mishra, Abhisek; Nayak, Bhagyalaxmi Less Cancer Research, Statistics, and Treatment. 5(1):52-58, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Significance of too-small-to-characteriz (TSTC) pulmonary nodules in known extrapulmonary solid tumors: A retrospective observational study Mahajan*, Abhishek; Monachen, Matthew; Shukla, Shreya; More Mahajan*, Abhishek; Monachen, Matthew; Shukla, Shreya; Agarwal, Ujjwal; Sable, Nilesh; Prabhash, Kumar; Rane, Swapnil; Thakur, Meenakshi Less Cancer Research, Statistics, and Treatment. 5(1):59-66, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Clinicopathologic features and outcomes of diffuse large B-cell lymphoma with extranodal involvement: A retrospective analysis Nair, Sukesh C.; Gogia, Ajay; Arora, Shalabh; More Nair, Sukesh C.; Gogia, Ajay; Arora, Shalabh; Kumar, Lalit; Sharma, Atul; Biswas, Ahitagni; Gupta, Ritu; Mallick, Saumyaranjan Less Cancer Research, Statistics, and Treatment. 5(1):67-74, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Timed Up and Go as a predictor of mortality in older Indian patients with cancer: An observational study Rao, Abhijith Rajaram; Kumar, Sharath; Dhekale, Ratan; More Rao, Abhijith Rajaram; Kumar, Sharath; Dhekale, Ratan; Krishnamurthy, Jyoti; Mahajan, Sarika; Daptardar, Anuradha; Ramaswamy, Anant; Noronha, Vanita; Gota, Vikram; Banavali, Shripad; Prabhash, Kumar Less Cancer Research, Statistics, and Treatment. 5(1):75-82, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
The Emancipation Chakrabarty, Nivedita Chakrabarty, Nivedita Less Cancer Research, Statistics, and Treatment. 5(1):83, Jan-Mar 2022. Favorite PDF Permissions Open
Superhero Rungta, Archi Rungta, Archi Less Cancer Research, Statistics, and Treatment. 5(1):84, Jan-Mar 2022. Favorite PDF Permissions Open
You can (cer) do it! Pendekanti, Ananya Pendekanti, Ananya Less Cancer Research, Statistics, and Treatment. 5(1):85-87, Jan-Mar 2022. Favorite PDF Permissions Open
Caregiving: A journey unacknowledged Mahajan, Vandana Mahajan, Vandana Less Cancer Research, Statistics, and Treatment. 5(1):88-89, Jan-Mar 2022. Favorite PDF Permissions Open
Body image disturbances among breast cancer survivors: A narrative review of prevalence and correlates Thakur, Monika; Sharma, Roopali; Mishra, Anand Kumar; More Thakur, Monika; Sharma, Roopali; Mishra, Anand Kumar; Gupta, Bandna Less Cancer Research, Statistics, and Treatment. 5(1):90-96, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
A narrative review of ERBB2 in non-small cell lung carcinoma Sharma, Mansi; Dewan, Abhinav; Diwan, Himanshi; More Sharma, Mansi; Dewan, Abhinav; Diwan, Himanshi; Nathany, Shrinidhi; Batra, Ullas Less Cancer Research, Statistics, and Treatment. 5(1):97-104, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Romiplostim – A narrative drug review Gupta, Anuj; Kapoor, Akhil; Choudhary, Amit; More Gupta, Anuj; Kapoor, Akhil; Choudhary, Amit; Kumar, Sujeet; Mishra, Bal Krishna Less Cancer Research, Statistics, and Treatment. 5(1):105-110, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
My experience with medical oncology fellowship training at the Tata Memorial Hospital Baldass, Mahamat Saleh Baldass, Mahamat Saleh Less Cancer Research, Statistics, and Treatment. 5(1):111-112, Jan-Mar 2022. Favorite PDF Permissions Open
Perceptions and realities about early mortality rates from COVID-19 in Indian patients with cancer Maka, Vinayak V; Devadas, Santhosh K. Maka, Vinayak V; Devadas, Santhosh K. Less Cancer Research, Statistics, and Treatment. 5(1):113-116, Jan-Mar 2022. Favorite PDF Permissions Open
Use of artificial intelligence on chest skiagrams in patients with COVID-19: Time to widen the horizon Kapoor, Atul Kapoor, Atul Less Cancer Research, Statistics, and Treatment. 5(1):116-118, Jan-Mar 2022. Favorite PDF Permissions Open
Extranodal diffuse large B-cell lymphoma: Real-world experience from an Indian tertiary cancer center Suresh Babu, M. C.; Sreevalli, A. Suresh Babu, M. C.; Sreevalli, A. Less Cancer Research, Statistics, and Treatment. 5(1):119-121, Jan-Mar 2022. Favorite PDF Permissions Open
EGFR exon 20 insertion in non-small cell lung cancer Panda, Goutam Santosh; Noronha, Vanita; Shetty, Omshree; More Panda, Goutam Santosh; Noronha, Vanita; Shetty, Omshree; Yadav, Subhash; Kumar, Rajiv; Patil, Vijay; Chandrani, Pratik; Janu, Amit; Mahajan, Abhishek; Chougule, Anuradha; Prabhash, Kumar Less Cancer Research, Statistics, and Treatment. 5(1):122-130, Jan-Mar 2022. Favorite PDF Permissions Open
Diagnostic quandary over a cheek(y) neoplasm Shukla, Shreya; Agarwal, Ujjwal; Patil, Vasundhara; More Shukla, Shreya; Agarwal, Ujjwal; Patil, Vasundhara; Rane, Swapnil; Menon, Nandini; Noronha, Vanita; Patil, Vijay; Prabhash, Kumar; Mahajan, Abhishek Less Cancer Research, Statistics, and Treatment. 5(1):131-135, Jan-Mar 2022. Favorite PDF Permissions Open
What's that in the infratemporal fossa? Mahajan, Abhishek; Ashtekar, Renuka; Agarwal, Ujjwal; More Mahajan, Abhishek; Ashtekar, Renuka; Agarwal, Ujjwal; Shukla, Shreya Less Cancer Research, Statistics, and Treatment. 5(1):136-138, Jan-Mar 2022. Favorite PDF Permissions Open
Are you confident about your confidence in confidence intervals? Darling, H. S. Darling, H. S. Less Cancer Research, Statistics, and Treatment. 5(1):139-144, Jan-Mar 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Problems associated with inadequate surgery in patients with cervical cancer: Can they be avoided? Verma, Mranalini; Srivastava, Kirti; Singhal, Sanjay Verma, Mranalini; Srivastava, Kirti; Singhal, Sanjay Less Cancer Research, Statistics, and Treatment. 5(1):145-147, Jan-Mar 2022. Favorite PDF Permissions Open
P values need to be correctly understood and read along with 95% confidence intervals Andrade, Chittaranjan Andrade, Chittaranjan Less Cancer Research, Statistics, and Treatment. 5(1):147-148, Jan-Mar 2022. Favorite PDF Permissions Open
Author's reply to Andrade Darling, H. S. Darling, H. S. Less Cancer Research, Statistics, and Treatment. 5(1):148-149, Jan-Mar 2022. Favorite PDF Permissions Open
Changing the paradigm of treatment in locally advanced breast cancers: Can we impact outcomes in resource-limited settings by improving pathological complete response? Iyer, Priya Iyer, Priya Less Cancer Research, Statistics, and Treatment. 5(1):149-150, Jan-Mar 2022. Favorite PDF Permissions Open
Pathological complete response in locally advanced breast cancer after neoadjuvant chemotherapy: Hope or hype Agarwal, Reshu; Kottarathil, Vijaykumar Dehannathparambil Agarwal, Reshu; Kottarathil, Vijaykumar Dehannathparambil Less Cancer Research, Statistics, and Treatment. 5(1):150-151, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Agarwal et al. and Iyer Gandhi, Ajeet Kumar; Gogia, Ajay Gandhi, Ajeet Kumar; Gogia, Ajay Less Cancer Research, Statistics, and Treatment. 5(1):152-153, Jan-Mar 2022. Favorite PDF Permissions Open
Day 14 bone marrow response assessment in acute myeloid leukemia: Should we discontinue? Chaudhary, Shilpi; Ganguly, Shuvadeep; Bakhshi, Sameer Chaudhary, Shilpi; Ganguly, Shuvadeep; Bakhshi, Sameer Less Cancer Research, Statistics, and Treatment. 5(1):153-154, Jan-Mar 2022. Favorite PDF Permissions Open
The day 14 conundrum still remains unresolved! Soni, Priyanka; Gupta, Naveen; Malhotra, Hemant Soni, Priyanka; Gupta, Naveen; Malhotra, Hemant Less Cancer Research, Statistics, and Treatment. 5(1):155-156, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Chaudhary et al. and Soni et al. Manuprasad, Avaronnan; Raghavan, Vineetha; Shenoy, Praveen K.; More Manuprasad, Avaronnan; Raghavan, Vineetha; Shenoy, Praveen K.; Krishnan, Aswathi; Nair, Chandran K. Less Cancer Research, Statistics, and Treatment. 5(1):156-157, Jan-Mar 2022. Favorite PDF Permissions Open
Profile and outcome of advanced malignant melanoma in India: Need for cost-effective innovations Ganguly, Shuvadeep; Bakhshi, Sameer Ganguly, Shuvadeep; Bakhshi, Sameer Less Cancer Research, Statistics, and Treatment. 5(1):157-158, Jan-Mar 2022. Favorite PDF Permissions Open
Indian real-world data on melanoma Arun, H. N. Arun, H. N. Less Cancer Research, Statistics, and Treatment. 5(1):158-159, Jan-Mar 2022. Favorite PDF Permissions Open
Malignant melanoma in India: Is it time to set the wheels in motion? Biswas, Bivas; Roy, Somnath; Ganguly, Sandip Biswas, Bivas; Roy, Somnath; Ganguly, Sandip Less Cancer Research, Statistics, and Treatment. 5(1):159-160, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Arun, Biswas et al., and Ganguly et al. Rastogi, Sameer; Shishak, Sorun; Mittal, Abhenil Rastogi, Sameer; Shishak, Sorun; Mittal, Abhenil Less Cancer Research, Statistics, and Treatment. 5(1):161-162, Jan-Mar 2022. Favorite PDF Permissions Open
Improving access to technology among older adults with cancer: Current perspectives and future priorities de-la-O-Murillo, Andrea; Soto-Perez-de-Celis, Enrique de-la-O-Murillo, Andrea; Soto-Perez-de-Celis, Enrique Less Cancer Research, Statistics, and Treatment. 5(1):162-163, Jan-Mar 2022. Favorite PDF Permissions Open
Making the seniors tech savvy: The way forward to bringing cancer care to the doorstep Prem, Naganath Narasimhan; Pillai, Anupa; Banerjee, Joyita Prem, Naganath Narasimhan; Pillai, Anupa; Banerjee, Joyita Less Cancer Research, Statistics, and Treatment. 5(1):163-164, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to de-la-O-Murillo and Soto-Perez-de-Celis, and Prem et al. Rao, Abhijith Rajaram; Noronha, Vanita; Ramaswamy, Anant; More Rao, Abhijith Rajaram; Noronha, Vanita; Ramaswamy, Anant; Prabhash, Kumar Less Cancer Research, Statistics, and Treatment. 5(1):164-165, Jan-Mar 2022. Favorite PDF Permissions Open
Is CROSS the right approach for locally advanced esophageal cancer in India? Arun, H. N. Arun, H. N. Less Cancer Research, Statistics, and Treatment. 5(1):165-166, Jan-Mar 2022. Favorite PDF Permissions Open
Neoadjuvant chemoradiation followed by surgery in operable carcinoma esophagus: Is the real-world scenario too far from clinical trial settings? Bhattacharyya, Tapesh; Mallick, Indranil; Singh, Moses Arun Bhattacharyya, Tapesh; Mallick, Indranil; Singh, Moses Arun Less Cancer Research, Statistics, and Treatment. 5(1):166-167, Jan-Mar 2022. Favorite PDF Permissions Open
Does the radiation dose in neoadjuvant chemoradiation in resectable esophageal carcinoma matter in the Indian scenario? Thammineedi, Subramanyeshwar Rao; Patnaik, Sujith Chyau; Nusrath, Syed Thammineedi, Subramanyeshwar Rao; Patnaik, Sujith Chyau; Nusrath, Syed Less Cancer Research, Statistics, and Treatment. 5(1):167-169, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Bhattacharyya et al., Thammineedi et al., and Arun Dora, Tapas Kumar; Aeron, Tushar; Chatterjee, Abhishek; More Dora, Tapas Kumar; Aeron, Tushar; Chatterjee, Abhishek; Deshmukh, Jayashree Less Cancer Research, Statistics, and Treatment. 5(1):169-171, Jan-Mar 2022. Favorite PDF Permissions Open
Is there a place today for augmented and virtual reality in cigarette smoking cessation? Chaturvedi, Pankaj; Singh, Arjun Chaturvedi, Pankaj; Singh, Arjun Less Cancer Research, Statistics, and Treatment. 5(1):172-173, Jan-Mar 2022. Favorite PDF Permissions Open
Future scope of virtual reality and augmented reality in tobacco control Priya, Harsh; Purohit, Bharathi M.; Ravi, Priyanka Priya, Harsh; Purohit, Bharathi M.; Ravi, Priyanka Less Cancer Research, Statistics, and Treatment. 5(1):173-174, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Singh and Chaturvedi, and Priya et al. Sandra, S. Canty; Raghavan, Anusha; Madan Kumar, P. D. Sandra, S. Canty; Raghavan, Anusha; Madan Kumar, P. D. Less Cancer Research, Statistics, and Treatment. 5(1):174-175, Jan-Mar 2022. Favorite PDF Permissions Open
Are we there RET? Jaiswal, Ashutosh; Chanana, Raajit Jaiswal, Ashutosh; Chanana, Raajit Less Cancer Research, Statistics, and Treatment. 5(1):175-176, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Jaiswal and Chanana Batra, Ullas; Nathany, Shrinidhi; Diwan, Himanshi Batra, Ullas; Nathany, Shrinidhi; Diwan, Himanshi Less Cancer Research, Statistics, and Treatment. 5(1):176-177, Jan-Mar 2022. Favorite PDF Permissions Open
Lenvatinib: With more power comes more toxicity Kumar, Shikhar Kumar, Shikhar Less Cancer Research, Statistics, and Treatment. 5(1):177-178, Jan-Mar 2022. Favorite PDF Permissions Open
Lenvatinib: A potent oral tyrosine kinase inhibitor across multiple histologies with differing dosages Sansar, Bipinesh; Singh, Neha; Singh, Arpita Sansar, Bipinesh; Singh, Neha; Singh, Arpita Less Cancer Research, Statistics, and Treatment. 5(1):178-179, Jan-Mar 2022. Favorite PDF Permissions Open
iT may improve prognostication but is not meant for staging in its current form Sreeram, M. P.; Subramaniam, Narayana Sreeram, M. P.; Subramaniam, Narayana Less Cancer Research, Statistics, and Treatment. 5(1):179-180, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Sreeram and Subramaniam Mahajan, Abhishek; Vaish, Richa; Shukla, Shreya; More Mahajan, Abhishek; Vaish, Richa; Shukla, Shreya; Agarwal, Ujjwal Less Cancer Research, Statistics, and Treatment. 5(1):181-182, Jan-Mar 2022. Favorite PDF Permissions Open
Immunotherapy for triple-negative breast cancer: Time to pause? Muddu, Vamshi Krishna; Boindala, Nanditha Muddu, Vamshi Krishna; Boindala, Nanditha Less Cancer Research, Statistics, and Treatment. 5(1):182-183, Jan-Mar 2022. Favorite PDF Permissions Open
Authors' reply to Muddu and Boindala Sharma, Rakesh; Gogia, Ajay Sharma, Rakesh; Gogia, Ajay Less Cancer Research, Statistics, and Treatment. 5(1):183-184, Jan-Mar 2022. Favorite PDF Permissions Open
M. masseter pars coronoidea: Gateway between the masticator space and infratemporal fossa Mahajan, Abhishek; Smriti, Vasundhara Mahajan, Abhishek; Smriti, Vasundhara Less Cancer Research, Statistics, and Treatment. 5(1):185-186, Jan-Mar 2022. Favorite PDF Permissions Open
Transplantation and maintenance in multiple myeloma appear to overcome differences in induction regimens Singh, Jagdeep; Joshi, Kaveri; Singh, Suvir Singh, Jagdeep; Joshi, Kaveri; Singh, Suvir Less Cancer Research, Statistics, and Treatment. 5(1):186-188, Jan-Mar 2022. Favorite PDF Permissions Open
Vemurafenib plus rituximab in relapsed or refractory hairy cell leukemia Baa, Annie Kanchan; Gogia, Ajay Baa, Annie Kanchan; Gogia, Ajay Less Cancer Research, Statistics, and Treatment. 5(1):188, Jan-Mar 2022. Favorite PDF Permissions Open
Organizational aspects of critical care in patients with hematologic malignancies and those undergoing stem cell transplantation Singh, Suvir; Gupta, Vivek K; Kaur, Gurkirat Singh, Suvir; Gupta, Vivek K; Kaur, Gurkirat Less Cancer Research, Statistics, and Treatment. 5(1):189-190, Jan-Mar 2022. Favorite PDF Permissions Open
Microbiota as a predictor of mortality in allogeneic hematopoietic cell transplantation Sharma, Rakesh; Gogia, Ajay; Baa, Annie Kanchan Sharma, Rakesh; Gogia, Ajay; Baa, Annie Kanchan Less Cancer Research, Statistics, and Treatment. 5(1):191-192, Jan-Mar 2022. Favorite PDF Permissions Open
Adjuvant pembrolizumab in renal cell carcinoma Raodha, Raghav; Gogia, Ajay; Baa, Annie Raodha, Raghav; Gogia, Ajay; Baa, Annie Less Cancer Research, Statistics, and Treatment. 5(1):191, Jan-Mar 2022. Favorite PDF Permissions Open
Secondary cytoreductive surgery in recurrent ovarian carcinoma Ganguly, Shuvadeep; Gogia, Ajay Ganguly, Shuvadeep; Gogia, Ajay Less Cancer Research, Statistics, and Treatment. 5(1):192-193, Jan-Mar 2022. Favorite PDF Permissions Open
Preparation is key: Prehabilitation for patients receiving high-dose chemotherapy and autologous stem cell transplant Singh, Suvir; Kaur, Gurkirat Singh, Suvir; Kaur, Gurkirat Less Cancer Research, Statistics, and Treatment. 5(1):193-194, Jan-Mar 2022. Favorite PDF Permissions Open
Is cabozantinib the common answer to all radioiodine-refractory differentiated thyroid cancers? Kapoor, Akhil; Patil, Vijay M.; Prabhash, Kumar Kapoor, Akhil; Patil, Vijay M.; Prabhash, Kumar Less Cancer Research, Statistics, and Treatment. 5(1):194-195, Jan-Mar 2022. Favorite PDF Permissions Open
Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer Ganguly, Shuvadeep; Gogia, Ajay Ganguly, Shuvadeep; Gogia, Ajay Less Cancer Research, Statistics, and Treatment. 5(1):195-196, Jan-Mar 2022. Favorite PDF Permissions Open
Relatlimab and nivolumab in untreated advanced melanoma Ganguly, Shuvadeep; Gogia, Ajay Ganguly, Shuvadeep; Gogia, Ajay Less Cancer Research, Statistics, and Treatment. 5(1):196-197, Jan-Mar 2022. Favorite PDF Permissions Open
